Strattera 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg hard capsules *
Pharmacy Only: Prescription

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 03 May 2021

File name

Strattera-OS_IE-UK_PIL_ST048_Jan21-2_1620067399.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to MA holder contact details

Updated on 29 January 2021

File name

Strattera-Caps_IE-UK-MT_PIL_Jan21_1611906819.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 29 January 2021

File name

Strattera-Caps_IE-UK-MT_PIL_Jan21_1611906819.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

Change to UK marketing authorisation holder only.  Update to latest ADR reporting requirements.

Updated on 29 July 2020

File name

ie-pil-en-caps-18_1532952849.pdf

Reasons for updating

  • XPIL Updated

Updated on 29 July 2020

File name

ie-pil-en-caps-18_1532952849.pdf

Reasons for updating

  • XPIL Updated

Updated on 28 July 2020

File name

ie-pil-en-caps-18_1532952849.pdf

Reasons for updating

  • XPIL Updated

Updated on 30 July 2018

File name

ie-pil-en-caps-18_1532952849.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 30 July 2018

File name

STRATTERA ROI SPC Jul18 ST37M_1532952732.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Transfer of Marketing authorisation holder from Eli Lilly UK (Basingstoke) to Eli Lilly Netherlands

Updated on 09 May 2018

File name

STRATTERA-ROI-SPC-May15-ST35M.docx

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 27 April 2018

File name

STRATTERA-ROI-SPC-May15-ST35M.docx

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 23 April 2018

File name

Strattera_caps_PIL_UK-IE-MT May 15.pdf

Reasons for updating

  • New PIL for new product